{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:22:17Z","timestamp":1788434537375,"version":"build-2803163510"},"reference-count":49,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"unspecified","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2025,12,11]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Sj\u00f6gren\u2019s disease (SjD) is a chronic systemic autoimmune disease with heterogeneous glandular and extraglandular manifestations. Although aetiology and pathogenesis of SjD remains elusive, emergence of autoreactive T and B lymphocytes is crucial in disease development. In this study, the metabolome of patients with SjD was characterised to improve disease understanding and to identify biomarkers as tools to aid drug development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>The metabolome was investigated in saliva, tears and plasma samples from two independent cohorts from Poland (PL) and the UK using a mass spectrometry screening platform with 4500 reference metabolites. The PL cohort included 30 healthy subjects and 32 patients with SjD. The UK cohort encompassed longitudinal samples from 13 healthy subjects and 12 patients with SjD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patient heterogeneity was reflected in the metabolome across all three matrices (plasma, saliva and tears) with consistent disturbances in the amino acid metabolism and transport pathway. A biomarker signature was developed using both cohorts, which allowed to characterise patients with milder and more severe disease activity. The relevance of the biomarker signature was supported by the presence of metabolites linked to pathways such as gamma-glutamyl cycle, pyrimidine metabolism and sex steroid hormones, which have previously been described to be deregulated in patients with SjD and other autoimmune diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A plasma metabolome biomarker signature was developed that can be implemented in clinical studies by simple blood collection. The biomarker signature allows to characterise disease activity of patients with SjD at baseline and provides a basis for future studies to investigate its potential utility in monitoring therapeutic intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/rmdopen-2025-006312","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T08:25:14Z","timestamp":1767687914000},"page":"e006312","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Sj\u00f6gren\u2019s disease metabolome reveals biomarker signatures to characterise patients and assess disease activity"],"prefix":"10.1136","volume":"12","author":[{"given":"Madeleine","family":"Suffiotti","sequence":"first","affiliation":[{"name":"Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Tanner","sequence":"additional","affiliation":[{"name":"Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz","family":"Kozera","sequence":"additional","affiliation":[{"name":"\u0141ukasiewicz Research Network - PORT Polish Center for Technology Development, Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Sebastian","sequence":"additional","affiliation":[{"name":"Department and Clinic of Rheumatology and Internal Medicine, Wroclaw Medical University, Wroc\u0142aw, Lower Silesian Voivodeship, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"van Maurik","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology and Experimental Medicine, GlaxoSmithKline Research and Development, Stevenage, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0097-1937","authenticated-orcid":false,"given":"Daniel","family":"Strasser","sequence":"additional","affiliation":[{"name":"Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"2026090304052665000_12.1.e006312.1","first-page":"10","article-title":"One year in review 2020: comorbidities, diagnosis and treatment of primary Sj\u00f6gren\u2019s syndrome","volume":"38 Suppl 126","author":"Manfr\u00e8","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"2026090304052665000_12.1.e006312.2","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s12325-017-0501-3","article-title":"The potential role for early biomarker testing as part of a modern, multidisciplinary approach to Sj\u00f6gren\u2019s syndrome diagnosis","volume":"34","author":"Beckman","year":"2017","journal-title":"Adv Ther"},{"key":"2026090304052665000_12.1.e006312.3","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67462-z","article-title":"Prevalence of Sj\u00f6gren\u2019s syndrome in the general adult population in Spain: estimating the proportion of undiagnosed cases","volume":"10","author":"Narv\u00e1ez","year":"2020","journal-title":"Sci Rep"},{"key":"2026090304052665000_12.1.e006312.4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216114"},{"key":"2026090304052665000_12.1.e006312.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2022.105406"},{"key":"2026090304052665000_12.1.e006312.6","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/1744666X.2021.1831915","article-title":"Stumbles in Sj\u00f6gren\u2019s syndrome drug development: where to look for the next big leap?","volume":"16","author":"Verstappen","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"2026090304052665000_12.1.e006312.7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218599"},{"key":"2026090304052665000_12.1.e006312.8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/eos.12536","article-title":"Current concepts on Sj\u00f6gren\u2019s syndrome - classification criteria and biomarkers","volume":"126 Suppl 1","author":"Jonsson","year":"2018","journal-title":"Eur J Oral Sci"},{"key":"2026090304052665000_12.1.e006312.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102590"},{"key":"2026090304052665000_12.1.e006312.10","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23472-7","article-title":"A new molecular classification to drive precision treatment strategies in primary Sj\u00f6gren\u2019s syndrome","volume":"12","author":"Soret","year":"2021","journal-title":"Nat Commun"},{"key":"2026090304052665000_12.1.e006312.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102738"},{"key":"2026090304052665000_12.1.e006312.12","doi-asserted-by":"crossref","first-page":"101475","DOI":"10.1016\/j.berh.2019.101475","article-title":"Toward better outcomes in Sj\u00f6gren\u2019s syndrome: The promise of a stratified medicine approach","volume":"34","author":"Noaiseh","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2026090304052665000_12.1.e006312.13","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-023-01399-3","article-title":"Small molecule metabolites: discovery of biomarkers and therapeutic targets","volume":"8","author":"Qiu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2026090304052665000_12.1.e006312.14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2334\/josnusd.19-0504","article-title":"Variability of salivary metabolite levels in patients with Sj\u00f6gren\u2019s syndrome","volume":"63","author":"Herrala","year":"2020","journal-title":"J Oral Sci"},{"key":"2026090304052665000_12.1.e006312.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2019.112999"},{"key":"2026090304052665000_12.1.e006312.16","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s10067-018-4021-6","article-title":"LC-MS-based serum metabolomics reveals a distinctive signature in patients with rheumatoid arthritis","volume":"37","author":"Li","year":"2018","journal-title":"Clin Rheumatol"},{"key":"2026090304052665000_12.1.e006312.17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159384","article-title":"Metabolic Profiling of Systemic Lupus Erythematosus and Comparison with Primary Sj\u00f6gren\u2019s Syndrome and Systemic Sclerosis","volume":"11","author":"Bengtsson","year":"2016","journal-title":"PLoS One"},{"key":"2026090304052665000_12.1.e006312.18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/cei.12683","article-title":"Metabolomics analysis of saliva from patients with primary Sj\u00f6gren\u2019s syndrome","volume":"182","author":"Kageyama","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"2026090304052665000_12.1.e006312.19","doi-asserted-by":"crossref","DOI":"10.3390\/cells11030323","article-title":"Saliva Metabolomics in Dry Mouth Patients with Head and Neck Cancer or Sj\u00f6gren\u2019s Syndrome","volume":"11","author":"Hynne","year":"2022","journal-title":"Cells"},{"key":"2026090304052665000_12.1.e006312.20","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-016-1006-1","article-title":"Identification of definitive serum biomarkers associated with disease activity in primary Sj\u00f6gren\u2019s syndrome","volume":"18","author":"Nishikawa","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2026090304052665000_12.1.e006312.21","first-page":"2211","article-title":"Sj\u00f6gren\u2019s syndrome: one year in review 2022","volume":"40","author":"Manfr\u00e8","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"2026090304052665000_12.1.e006312.22","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1093\/rheumatology\/keaa624","article-title":"Advanced imaging for quantification of abnormalities in the salivary glands of patients with primary Sj\u00f6gren\u2019s syndrome","volume":"60","author":"Jimenez-Royo","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2026090304052665000_12.1.e006312.23","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2014-000022","article-title":"EULAR Sj\u00f6gren\u2019s syndrome disease activity index (ESSDAI): a user guide","volume":"1","author":"Seror","year":"2015","journal-title":"RMD Open"},{"key":"2026090304052665000_12.1.e006312.24","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.110619"},{"key":"2026090304052665000_12.1.e006312.25","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.143743"},{"key":"2026090304052665000_12.1.e006312.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9868.2005.00503.x"},{"key":"2026090304052665000_12.1.e006312.27","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.8986.2","article-title":"Bioconductor Workflow for Microbiome Data Analysis: from raw reads to community analyses","volume":"5","author":"Callahan","year":"2016","journal-title":"F1000Res"},{"key":"2026090304052665000_12.1.e006312.28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/odi.13191","article-title":"Saliva microbiome in primary Sj\u00f6gren\u2019s syndrome reveals distinct set of disease-associated microbes","volume":"26","author":"Sharma","year":"2020","journal-title":"Oral Dis"},{"key":"2026090304052665000_12.1.e006312.29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218319","article-title":"Dysbiotic salivary microbiota in dry mouth and primary Sj\u00f6gren\u2019s syndrome patients","volume":"14","author":"Rusthen","year":"2019","journal-title":"PLoS One"},{"key":"2026090304052665000_12.1.e006312.30","doi-asserted-by":"crossref","DOI":"10.1038\/srep23561","article-title":"Altered Mucosal Microbiome Diversity and Disease Severity in Sj\u00f6gren Syndrome","volume":"6","author":"de Paiva","year":"2016","journal-title":"Sci Rep"},{"key":"2026090304052665000_12.1.e006312.31","doi-asserted-by":"crossref","DOI":"10.3390\/v11080762","article-title":"Viruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms","volume":"11","author":"Smatti","year":"2019","journal-title":"Viruses"},{"key":"2026090304052665000_12.1.e006312.32","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1474-4422(22)00471-9","article-title":"Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy","volume":"22","author":"Aloisi","year":"2023","journal-title":"Lancet Neurol"},{"key":"2026090304052665000_12.1.e006312.33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.823659","article-title":"The role of virus infections in Sj\u00f6gren\u2019s syndrome","volume":"13","author":"Maslinska","year":"2022","journal-title":"Front Immunol"},{"key":"2026090304052665000_12.1.e006312.34","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s40744-021-00334-8","article-title":"Sj\u00f6gren\u2019s Syndrome and Viral Infections","volume":"8","author":"Liu","year":"2021","journal-title":"Rheumatol Ther"},{"key":"2026090304052665000_12.1.e006312.35","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/art.42265","article-title":"Variability of Primary Sj\u00f6gren\u2019s Syndrome Is Driven by Interferon-\u03b1 and Interferon-\u03b1 Blood Levels Are Associated With the Class II HLA-DQ Locus","volume":"74","author":"Trutschel","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2026090304052665000_12.1.e006312.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110236"},{"key":"2026090304052665000_12.1.e006312.37","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4267"},{"key":"2026090304052665000_12.1.e006312.38","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2105390118","article-title":"STING-driven interferon signaling triggers metabolic alterations in pancreas cancer cells visualized by [18F]FLT PET imaging","volume":"118","author":"Liang","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026090304052665000_12.1.e006312.39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003678","article-title":"Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity","volume":"9","author":"Lucas-Hourani","year":"2013","journal-title":"PLoS Pathog"},{"key":"2026090304052665000_12.1.e006312.40","first-page":"1157","article-title":"Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin","volume":"11","author":"Perl","year":"2015","journal-title":"Metabolomics (Los Angel)"},{"key":"2026090304052665000_12.1.e006312.41","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-00881-3"},{"key":"2026090304052665000_12.1.e006312.42","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122312","article-title":"Integrated, multicohort analysis reveals unified signature of systemic lupus erythematosus","volume":"5","author":"Haynes","year":"2020","journal-title":"JCI Insight"},{"key":"2026090304052665000_12.1.e006312.43","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3389\/fimmu.2019.00795","article-title":"Elevated CCL19\/CCR7 Expression During the Disease Process of Primary Sj\u00f6gren\u2019s Syndrome","volume":"10","author":"Liu","year":"2019","journal-title":"Front Immunol"},{"key":"2026090304052665000_12.1.e006312.44","doi-asserted-by":"publisher","DOI":"10.1172\/JCI160852"},{"key":"2026090304052665000_12.1.e006312.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.11.001"},{"key":"2026090304052665000_12.1.e006312.46","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201540861"},{"key":"2026090304052665000_12.1.e006312.47","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.2943"},{"key":"2026090304052665000_12.1.e006312.48","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0106"},{"key":"2026090304052665000_12.1.e006312.49","first-page":"1259","article-title":"Low serum dehydroepiandrosterone sulfate in women with primary Sj\u00f6gren\u2019s syndrome as an isolated sign of impaired HPA axis function","volume":"28","author":"Valtysd\u00f3ttir","year":"2001","journal-title":"J Rheumatol"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2025-006312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:05:37Z","timestamp":1788433537000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2025-006312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,5]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/rmdopen-2025-006312"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2025-006312","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}